Trials / Unknown
UnknownNCT04199962
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
Genomic Approaches for Predicting Severity of Organ Dysfunction and Outcomes in Sepsis: a Prospective Cohort Study in Adult Critically Ill Patients With Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a prospective cohort study using gene expression to study patients with infection and sepsis from pneumonia.
Detailed description
This is a prospective cohort study using single cell transcriptomic profiling and plasma DNA tissue mapping on patients with pneumonia with or without sepsis. The major application of the investigator's study would be the discovery of gene expressions in different leucocytes and plasma DNA associated with each type of organ dysfunction in sepsis. These include cardiovascular, respiratory, hepatic, renal, neurological and haematological dysfunction. This would help prediction, diagnosis and development of therapies to treat sepsis. Leucocyte single cell transcriptome and plasma DNA tissue mapping may addresses the limitations of current evidence in 3 ways: (1) differentiate patients with uncomplicated pneumonia versus pneumonia with associated sepsis, (2) correlation with types and severity of organ dysfunction and (3) identifying molecular phenotypes of sepsis.
Conditions
Timeline
- Start date
- 2019-12-12
- Primary completion
- 2022-11-11
- Completion
- 2023-12-31
- First posted
- 2019-12-16
- Last updated
- 2021-01-29
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04199962. Inclusion in this directory is not an endorsement.